Publications by authors named "Gin Yi Lee"
Background: Previous randomized controlled trials have established the efficacy of dupilumab among patients with chronic obstructive pulmonary disease (COPD) treated with triple therapy over 52 weeks of follow-up.
Objective: This population-based cohort study aimed to explore the long-term safety and effectiveness of dupilumab in patients with COPD.
Methods: The study included US patients with COPD who were seen between April 2017 and August 2024.
Background: In-hospital cardiac arrest (IHCA) carries a high mortality and significant morbidity in survivors. Gastrointestinal bleeding (GIB) can complicate cardiac arrests. We aim to study the association between GIB and the in-hospital outcomes of patients with IHCA.
View Article and Find Full Text PDFContext: Whether proton pump inhibitors (PPI) can improve glycemic control among individuals with diabetes or decrease the risk of incident diabetes in the general population is unclear.
Objective: To evaluate the impact of PPI therapy on glycemic control among individuals with diabetes and the risk of diabetes among those without diabetes.
Results: PubMed, Embase, Scopus, and ClinicalTrials.
Vertebral fractures affect approximately 30% of myeloma patients and lead to a poor impact on survival and life quality. In general, age and body mass index (BMI) are reported to have an important role in vertebral fractures. However, the triangle relationship among age, BMI, and vertebral fractures is still unclear in newly diagnosed multiple myeloma (NDMM) patients.
View Article and Find Full Text PDFArticle Synopsis
- Cerebrovascular events are a significant concern for cancer patients, and this study focused on identifying stroke risk factors in those with multiple myeloma.
- A total of 395 newly diagnosed patients were analyzed over 18 months, revealing that 16 experienced cerebrovascular events, with specific risk factors such as κ light chain isotype and high serum creatinine levels significantly increasing stroke risk.
- The findings emphasize the need for tailored stroke-prevention strategies in multiple myeloma patients, particularly considering the independent risks identified for both ischemic and hemorrhagic strokes.